未登录Influence of metabolic dysfunction-associated steatotic liver disease and metabolic risk factors on immunotherapy outcomes in hepatocellular carcinoma with chronic hepatitis B代谢功能障碍相关脂肪性肝病和代谢危险因素对慢性乙型肝炎相关肝细胞癌免疫治疗效果的影响
Wu, Xin-Tong; Yi, Jun-Zhe; Zhang, Yi-Min; Wang, Jiong-Liang; Li, Lei; Zeng, Jiang-Zheng; Ding, Ke; Fan, Yu-Wen; Liu, Xin; Zhu, Zhi-Jian; Yuan, Dao-Zu; Ning, Shang-Fu; Zhang, Jian-Zhong; You, Yong-Fei; Xu, Jie; Guo, Rong-Ping; Chen, Min-Shan; Zhao, Ming; Lyu, Ning
分享
收藏Prognosis prediction of α-FAtE score for locoregional immunotherapy in hepatocellular carcinoma
Zheng, Zehao; Guan, Renguo; Zhao, Rongce; Gan, Junyu; Xiong, Xinhao; Zou, Jing-wen; Li, Shaohua; Wang, Qiaoxuan; Wei, Wei; Mei, Jie; Guo, Rongping
分享
收藏Oxaliplatin induces pyroptosis in hepatoma cells and enhances antitumor immunity against hepatocellular carcinoma
Deng, Min; Zhao, Rongce; Zou, Hao; Guan, Renguo; Wang, Jiongliang; Lee, Carol; He, Benyi; Zhou, Jing; Li, Shaohua; Wei, Wei; Cai, Hao; Guo, Rongping
分享
收藏
分享
收藏Comparing PD-L1 with PD-1 antibodies combined with lenvatinib and hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinomaPD-1抗体联合来伐替尼与肝动脉灌注化疗治疗不可切除肝癌的PD-L1比较
Li, Shaohua; Mei, Jie; Zhao, Rongce; Zhou, Jing; Wang, Qiaoxuan; Lu, Lianghe; Li, Jibin; Zheng, Lie; Wei, Wei; Guo, Rongping
分享
收藏
分享
收藏Patients with hepatocellular carcinoma extrahepatic metastases can benefit from hepatic arterial infusion chemotherapy combined with lenvatinib plus programmed death-1 inhibitors
Guan, Renguo; Zhang, Nan; Deng, Min; Lin, Ye; Huang, Guanjie; Fu, Yizhen; Zheng, Zehao; Wei, Wei; Zhong, Chong; Zhao, Haitao; Mei, Jie; Guo, Rongping
分享
收藏
分享
收藏Nomograms for predicting the recurrence probability and recurrence-free survival in patients with hepatocellular carcinoma after conversion hepatectomy based on hepatic arterial infusion chemotherapy: a multicenter, retrospective study
Deng, Min; Lei, Qiucheng; Wang, Jiamin; Lee, Carol; Guan, Renguo; Li, Shaohua; Wei, Wei; Chen, Huanwei; Zhong, Chong; Guo, Rongping
分享
收藏